SCHEMBL8285237

SCHEMBL8285237

Cc1nc2c(cc1C(=O)O)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
HPGD P15428 3/20 0.41
KDM4E B2RXH2 1/20 0.41
PDE11A Q9HCR9 1/20 0.41
GAA P10253 3/20 0.40
GFER P55789 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NOTUM Q6P988 2/20 0.39
MAPK1 P28482 1/20 0.38
RXRA P19793 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 2/20 0.37
RECQL P46063 1/20 0.37
RCE1 Q9Y256 1/20 0.37
NGLY1 Q96IV0 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285200 0.90 MAPK1 (0.44) ALDH1A1HPGDKDM4EPDE11AMEN1
SCHEMBL8287153 0.90 MAPT (0.40) ALDH1A1HPGDKDM4EPDE11AGAA
SCHEMBL8285197 0.89 CXCR2 (0.39) ALDH1A1HPGDKDM4EPDE11AGAA
SCHEMBL8285210 0.88 PDE11A (0.44) ALDH1A1HPGDKDM4EPDE11AGAA
SCHEMBL8287199 0.87 PDCD1 (0.40) ALDH1A1HPGDKDM4EPDE11AGAA
SCHEMBL8285199 0.87 CSF1R (0.47) ALDH1A1HPGDKDM4EGAAMEN1
SCHEMBL5871894 0.86 PDE11A (0.43) ALDH1A1HPGDKDM4EPDE11AGAA
SCHEMBL8285215 0.86 CNR2 (0.44) PDE11AMAPK1MAPTPDE4BLMNA
SCHEMBL8287170 0.85 PDE11A (0.38) HPGDPDE11AGAAMEN1KMT2A
SCHEMBL8287451 0.85 PDE11A (0.42) ALDH1A1HPGDKDM4EPDE11AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed